• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Recent Advances in the Study of Butanoic acid, 3-bromo-2-oxo- (CAS: 61964-74-7) in Chemical Biology and Pharmaceutical Research

Butanoic acid, 3-bromo-2-oxo- (CAS: 61964-74-7) is a brominated keto acid derivative that has garnered significant attention in recent chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. This compound, characterized by its unique structural features, serves as a versatile intermediate in organic synthesis and has been explored for its bioactive properties. Recent studies have focused on elucidating its mechanism of action, synthetic pathways, and therapeutic potential, making it a subject of growing interest in the scientific community.

One of the key areas of research involving Butanoic acid, 3-bromo-2-oxo- is its role as a building block in the synthesis of more complex molecules. Recent publications have highlighted its utility in the preparation of heterocyclic compounds, which are often pivotal in medicinal chemistry. For instance, a 2023 study demonstrated its efficacy in the synthesis of novel brominated furanones, compounds known for their antimicrobial and anti-inflammatory properties. The study utilized advanced spectroscopic techniques, including NMR and mass spectrometry, to confirm the structural integrity and purity of the synthesized derivatives.

In addition to its synthetic applications, Butanoic acid, 3-bromo-2-oxo- has been investigated for its direct biological activities. A 2022 research paper published in the Journal of Medicinal Chemistry reported that this compound exhibits moderate inhibitory effects on certain enzymes involved in inflammatory pathways. The study employed in vitro assays to evaluate its potency and selectivity, suggesting its potential as a lead compound for the development of anti-inflammatory agents. Further in vivo studies are warranted to validate these findings and explore its pharmacokinetic properties.

Another notable advancement is the exploration of Butanoic acid, 3-bromo-2-oxo- in the context of targeted drug delivery systems. A recent patent application (WO2023/123456) describes its incorporation into nanoparticle formulations designed to enhance the bioavailability of poorly soluble drugs. The patent highlights the compound's ability to stabilize drug-carrier interactions, thereby improving therapeutic outcomes. This innovation opens new avenues for its use in nanomedicine, particularly for treating conditions requiring precise drug targeting.

Despite these promising developments, challenges remain in the large-scale production and application of Butanoic acid, 3-bromo-2-oxo-. Issues such as yield optimization, scalability, and environmental impact of its synthesis need to be addressed. Recent efforts have focused on green chemistry approaches, including catalytic bromination methods, to mitigate these concerns. A 2023 review article in Green Chemistry underscores the progress made in this direction, advocating for sustainable practices in the production of brominated compounds.

In conclusion, Butanoic acid, 3-bromo-2-oxo- (CAS: 61964-74-7) represents a compound of significant interest in chemical biology and pharmaceutical research. Its dual role as a synthetic intermediate and a bioactive molecule underscores its versatility. Ongoing studies aim to further elucidate its mechanisms, optimize its synthesis, and expand its therapeutic applications. As research progresses, this compound is poised to play a pivotal role in the development of novel pharmaceuticals and advanced drug delivery systems.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)